Publication | Open Access
Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776
102
Citations
30
References
2013
Year
Together, our results suggest that MK8776 selectively sensitizes HRR-proficient pancreatic cancer cells and xenografts to gemcitabine-radiation and support the clinical investigation of MK8776 in combination with gemcitabine-radiation in locally advanced pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1